Aldosterone/mineralocorticoid receptor stimulation induces cellular senescence in the kidney

Endocrinology

Volumn 152, Issue 2, 2011, Pages 680-688

  Fan, Yu Yan ^a   Kohno, Masakazu ^a   Hitomi, Hirofumi ^b   Kitada, Kento ^b   Fujisawa, Yoshihide ^a   Yatabe, Junichi ^c   Yatabe, Midori ^c   Felder, Robin A ^c   Ohsaki, Hiroyuki ^d,e   Rafiq, Kazi ^b   Sherajee, Shamshad J ^b   Noma, Takahisa ^a   Nishiyama, Akira ^b   Nakano, Daisuke ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALDOSTERONE; ALDOSTERONE RECEPTOR; ANTIOXIDANT; BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR; DRINKING WATER; EPLERENONE; HYDRALAZINE; MINERALOCORTICOID RECEPTOR; PROTEIN P53; SIRTUIN 1;

ANIMAL EXPERIMENT; ARTICLE; CELL AGING; GENE SILENCING; HYPERTENSION; KIDNEY INJURY; KIDNEY TUBULE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION; WOUND HEALING;

ACETYLGLUCOSAMINIDASE; ALDOSTERONE; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CELL AGING; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; HYDRALAZINE; HYPERTENSION; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIRTUIN 1; SPIRONOLACTONE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79951587283     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0829     Document Type: Article

References (47)

1. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y 2004 Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 43:841-848 (Pubitemid 38405598)
2. Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL 2004 Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol 93:990-996 (Pubitemid 38479452)
3. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C 2006 Long-term renal outcomes in patients with primary aldosteronism. JAMA 295:2638-2645 (Pubitemid 43882339)
4. Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T 2007 Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 49:355-364 (Pubitemid 46143013)
5. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG 2008 The aging kidney. Kidney Int 74:710-720
6. Hayflick L 2003 Living forever and dying in the attempt. Exp Gerontol 38:1231-1241 (Pubitemid 38041210)
7. Ohtani N, Imamura Y, Yamakoshi K, Hirota F, Nakayama R, Kubo Y, Ishimaru N, Takahashi A, Hirao A, Shimizu T, Mann DJ, Saya H, Hayashi Y, Arase S, Matsumoto M, Kazuki N, Hara E 2007 Visualizing the dynamics of p21(Waf1/Cip1) cyclin-dependent kinase inhibitor expression in living animals. Proc Natl Acad Sci USA 104:15034-15039 (Pubitemid 47619588)
8. Melk A, Kittikowit W, Sandhu I, Halloran KM, Grimm P, Schmidt BM, Halloran PF 2003 Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int 63:2134-2143 (Pubitemid 36605824)
9. Westhoff JH, Hilgers KF, Steinbach MP, Hartner A, Klanke B, Amann K, Melk A 2008 Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension 52:123-129
10. Kunieda T, Minamino T, Nishi J, Tateno K, Oyama T, Katsuno T, Miyauchi H, Orimo M, Okada S, Takamura M, Nagai T, Kaneko S, Komuro I 2006 Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 114:953-960 (Pubitemid 44337139)
11. Leo JC, Guo C, Woon CT, Aw SE, Lin VC 2004 Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells. Endocrinology 145:1314-1321 (Pubitemid 38281015)
12. Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M, Horiuchi M 2007 Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. Cardiovasc Res 76:506-516 (Pubitemid 350007454)
13. Kellner M, Peiter A, Hafner M, Feuring M, Christ M, Wehling M, Falkenstein E, Losel R 2003 Early aldosterone up-regulated genes: new pathways for renal disease? Kidney Int 64:1199-1207
14. Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki T, Kiyomoto H, Kohno M, Shokoji T, Kimura S, Abe Y 2004 The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol 15:306-315 (Pubitemid 38140771)
15. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I 2002 Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105:1541-1544 (Pubitemid 34297628)
16. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J 1995 A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367
17. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE 2004 Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299-1307 (Pubitemid 40385301)
18. Nishiyama A, Yao L, Fan Y, Kyaw M, Kataoka N, Hashimoto K, Nagai Y, Nakamura E, Yoshizumi M, Shokoji T, Kimura S, Kiyomoto H, Tsujioka K, Kohno M, Tamaki T, Kajiya F, Abe Y 2005 Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 45:710-716 (Pubitemid 40418370)
19. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J 2007 Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100:1512-1521 (Pubitemid 46834764)
20. Min LJ, Mogi M, Li JM, Iwanami J, Iwai M, Horiuchi M 2005 Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ Res 97:434-442 (Pubitemid 41298173)
21. Du J, Fan YY, Hitomi H, Kiyomoto H, Kimura S, Kong CZ, Noma T, Kohno M, Nishiyama A, Nakano D 2009 Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats. Am J Physiol Renal Physiol 297:F802-F808
22. Burt D, Salvidio G, Tarabra E, Barutta F, Pinach S, Dentelli P, Camussi G, Perin PC, Gruden G 2007 The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes. Am J Pathol 171:1789-1799
23. Maeshima A, Yamashita S, Nojima Y 2003 Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol 14:3138-3146 (Pubitemid 37509291)
24. Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang GX, Sun GP, Kimura S, Yukimura T, Kiyomoto H, Kohno M, Abe Y, Nishiyama A 2005 Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 16:2906-2912 (Pubitemid 44743488)
25. Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A 2005 Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 46:1039-1045
26. Colavitti R, Finkel T 2005 Reactive oxygen species as mediators of cellular senescence. IUBMB Life 57:277-281 (Pubitemid 40904255)
27. Patni H, Mathew JT, Luan L, Franki N, Chander PN, Singhal PC 2007 Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress. Am J Physiol Renal Physiol 293:F1065-F1071 (Pubitemid 47583938)
28. Zhang A, Jia Z, Guo X, Yang T 2007 Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol 293:F723-F731 (Pubitemid 47403342)
29. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717 (Pubitemid 29407370)
30. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321 (Pubitemid 36384098)
31. Fan YY, Baba R, Nagai Y, Miyatake A, Hosomi N, Kimura S, Sun GP, Kohno M, Fujita M, Abe Y, Nishiyama A 2006 Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan. Hypertens Res 29:169-178
32. Megyesi J, Price PM, Tamayo E, Safirstein RL 1999 The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc Natl Acad Sci USA 96:10830-10835 (Pubitemid 29442229)
33. Lane DP 1992 Cancer. p53, guardian of the genome. Nature 358:15-16
34. Classon M, Harlow E 2002 The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2:910-917 (Pubitemid 37328892)
35. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R 1993 The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038 (Pubitemid 24014559)
36. Minamino T, Komuro I 2008 Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat Clin Pract Cardiovasc Med 5:637-648
37. Zhang XP, Liu F, Cheng Z, Wang W 2009 Cell fate decision mediated by p53 pulses. Proc Natl Acad Sci USA 106:12245-12250
38. Fan YY, Kohno M, Nakano D, Hitomi H, Nagai Y, Fujisawa Y, Lu XM, Fu H, Du J, Ohmori K, Hosomi N, Kimura S, Kiyomoto H, Nishiyama A 2009 Inhibitory effects of a dihydropyridine calcium channel blocker on renal injury in aldosterone-infused rats. J Hypertens 27:1855-1862
39. Miura R, Nakamura K, Miura D, Miura A, Hisamatsu K, Kajiya M, Hashimoto K, Nagase S, Morita H, Fukushima Kusano K, Emori T, Ishihara K, Ohe T 2006 Aldosterone synthesis and cytokine production in human peripheral blood mononuclear cells. J Pharmacol Sci 102:288-295 (Pubitemid 44790690)
40. Abdelmohsen K, Pullmann Jr R, Lal A, Kim HH, Galban S, Yang X, Blethrow JD, Walker M, Shubert J, Gillespie DA, Furneaux H, Gorospe M 2007 Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25:543-557 (Pubitemid 46274441)
41. Rigotti P, Ekser B, Furian L, Baldan N, Valente ML, Boschiero L, Motterlini N, Perna A, Remuzzi G, Ruggenenti P 2009 Outcome of renal transplantation from very old donors. N Engl J Med 360:1464-1465
42. Melk A, Schmidt BM, Braun H, Vongwiwatana A, Urmson J, Zhu LF, Rayner D, Halloran PF 2009 Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant 9:114-123
43. Chkhotua AB, Altimari A, Gabusi E, D'Errico A, Yakubovich M, Vienken J, Stefoni S, Chieco P, Yussim A, Grigioni WF 2003 Increased expression of P21((WAF1/CIP1)) CDKI gene in chronic allograft nephropathy correlating with the number of acute rejection episodes. Transplant Proc 35:655-658 (Pubitemid 36338104)
44. Terada Y, Kobayashi T, Kuwana H, Tanaka H, Inoshita S, Kuwahara M, Sasaki S 2005 Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A. J Am Soc Nephrol 16:2296-2305 (Pubitemid 41725047)
45. Mihailidou AS, Loan Le TY, Mardini M, Funder JW 2009 Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54:1306-1312
46. Ortiz RM, Graciano ML, Seth D, Awayda MS, Navar LG 2007 Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in ANGII-dependent hypertension. Am J Physiol Renal Physiol 293:F139-F147 (Pubitemid 47345012)
47. Henschkowski J, Stuck AE, Frey BM, Gillmann G, Dick B, Frey FJ, Mohaupt MG 2008 Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients. Am J Hypertens 21:644-649 (Pubitemid 351733361)